25 XP   0   0   10

Universe Pharmaceuticals Inc
Buy, Hold or Sell?

Let's analyse Universe Pharmaceuticals Inc together

PenkeI guess you are interested in Universe Pharmaceuticals Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Universe Pharmaceuticals Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Universe Pharmaceuticals Inc

I send you an email if I find something interesting about Universe Pharmaceuticals Inc.

Quick analysis of Universe Pharmaceuticals Inc (30 sec.)










What can you expect buying and holding a share of Universe Pharmaceuticals Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
33.3%

What is your share worth?

Current worth
$10.84
Expected worth in 1 year
$3.26
How sure are you?
66.7%

+ What do you gain per year?

Total Gains per Share
$-7.58
Return On Investment
-366.2%

For what price can you sell your share?

Current Price per Share
$2.07
Expected price per share
$1.1373 - $2.88
How sure are you?
50%

1. Valuation of Universe Pharmaceuticals Inc (5 min.)




Live pricePrice per Share (EOD)

$2.07

Intrinsic Value Per Share

$-27.40 - $2.26

Total Value Per Share

$-16.56 - $13.10

2. Growth of Universe Pharmaceuticals Inc (5 min.)




Is Universe Pharmaceuticals Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$39.5m$46.4m-$6.9m-17.5%

How much money is Universe Pharmaceuticals Inc making?

Current yearPrevious yearGrowGrow %
Making money-$6.1m-$8.7m$2.5m41.8%
Net Profit Margin-19.1%-21.8%--

How much money comes from the company's main activities?

3. Financial Health of Universe Pharmaceuticals Inc (5 min.)




What can you expect buying and holding a share of Universe Pharmaceuticals Inc? (5 min.)

Welcome investor! Universe Pharmaceuticals Inc's management wants to use your money to grow the business. In return you get a share of Universe Pharmaceuticals Inc.

What can you expect buying and holding a share of Universe Pharmaceuticals Inc?

First you should know what it really means to hold a share of Universe Pharmaceuticals Inc. And how you can make/lose money.

Speculation

The Price per Share of Universe Pharmaceuticals Inc is $2.07. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Universe Pharmaceuticals Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Universe Pharmaceuticals Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $10.84. Based on the TTM, the Book Value Change Per Share is $-1.90 per quarter. Based on the YOY, the Book Value Change Per Share is $-3.43 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Universe Pharmaceuticals Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-1.69-81.7%-1.69-81.7%-2.40-115.8%0.6330.2%0.5828.1%
Usd Book Value Change Per Share-1.90-91.6%-1.90-91.6%-3.43-165.5%2.08100.3%1.8187.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.8742.1%0.7536.2%
Usd Total Gains Per Share-1.90-91.6%-1.90-91.6%-3.43-165.5%2.95142.4%2.56123.5%
Usd Price Per Share0.95-0.95-0.57-0.80-0.66-
Price to Earnings Ratio-0.56--0.56--0.24-0.00-0.00-
Price-to-Total Gains Ratio-0.50--0.50--0.16--0.14--0.14-
Price to Book Ratio0.09-0.09-0.04-0.06-0.05-
Price-to-Total Gains Ratio-0.50--0.50--0.16--0.14--0.14-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.07
Number of shares483
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.87
Usd Book Value Change Per Share-1.902.08
Usd Total Gains Per Share-1.902.95
Gains per Quarter (483 shares)-915.351,423.59
Gains per Year (483 shares)-3,661.415,694.35
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-3661-3671168340125684
20-7323-73323366802311378
30-10984-1099350481203517072
40-14646-1465467311604622766
50-18307-1831584142005828460
60-21968-21976100972406934154
70-25630-25637117802808139848
80-29291-29298134623209245542
90-32953-32959151453610451236
100-36614-36620168284011556930

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%4.02.00.066.7%4.02.00.066.7%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%4.02.00.066.7%4.02.00.066.7%
Dividend per Share0.00.01.00.0%0.00.03.00.0%1.00.04.020.0%2.00.04.033.3%2.00.04.033.3%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%4.02.00.066.7%4.02.00.066.7%

Fundamentals of Universe Pharmaceuticals Inc

About Universe Pharmaceuticals Inc

Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. The company also distributes and sells third-party products, including biomedical drugs, medical instruments, traditional Chinese medicine pieces, and dietary supplements. Its customers include pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was founded in 1998 and is based in Ji'An, China. Universe Pharmaceuticals INC operates as a subsidiary of Sununion Holding Group Limited.

Fundamental data was last updated by Penke on 2024-04-12 21:05:06.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Universe Pharmaceuticals Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Universe Pharmaceuticals Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Universe Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -19.1% means that $-0.19 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Universe Pharmaceuticals Inc:

  • The MRQ is -19.1%. The company is making a huge loss. -2
  • The TTM is -19.1%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-19.1%TTM-19.1%0.0%
TTM-19.1%YOY-21.8%+2.7%
TTM-19.1%5Y6.0%-25.1%
5Y6.0%10Y9.5%-3.4%
1.1.2. Return on Assets

Shows how efficient Universe Pharmaceuticals Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Universe Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • -11.6% Return on Assets means that Universe Pharmaceuticals Inc generated $-0.12 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Universe Pharmaceuticals Inc:

  • The MRQ is -11.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -11.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-11.6%TTM-11.6%0.0%
TTM-11.6%YOY-14.7%+3.1%
TTM-11.6%5Y11.7%-23.3%
5Y11.7%10Y14.3%-2.6%
1.1.3. Return on Equity

Shows how efficient Universe Pharmaceuticals Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Universe Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • -15.6% Return on Equity means Universe Pharmaceuticals Inc generated $-0.16 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Universe Pharmaceuticals Inc:

  • The MRQ is -15.6%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -15.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-15.6%TTM-15.6%0.0%
TTM-15.6%YOY-18.8%+3.2%
TTM-15.6%5Y16.4%-32.0%
5Y16.4%10Y26.8%-10.4%

1.2. Operating Efficiency of Universe Pharmaceuticals Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Universe Pharmaceuticals Inc is operating .

  • Measures how much profit Universe Pharmaceuticals Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Universe Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of -12.9% means the company generated $-0.13  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Universe Pharmaceuticals Inc:

  • The MRQ is -12.9%. The company is operating very inefficient. -2
  • The TTM is -12.9%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-12.9%TTM-12.9%0.0%
TTM-12.9%YOY-17.5%+4.6%
TTM-12.9%5Y12.1%-25.0%
5Y12.1%10Y15.8%-3.7%
1.2.2. Operating Ratio

Measures how efficient Universe Pharmaceuticals Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.12 means that the operating costs are $1.12 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Universe Pharmaceuticals Inc:

  • The MRQ is 1.123. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.123. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.123TTM1.1230.000
TTM1.123YOY1.175-0.052
TTM1.1235Y0.875+0.248
5Y0.87510Y0.839+0.036

1.3. Liquidity of Universe Pharmaceuticals Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Universe Pharmaceuticals Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 2.68 means the company has $2.68 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Universe Pharmaceuticals Inc:

  • The MRQ is 2.676. The company is able to pay all its short-term debts. +1
  • The TTM is 2.676. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.676TTM2.6760.000
TTM2.676YOY3.169-0.493
TTM2.6765Y3.100-0.424
5Y3.10010Y2.782+0.318
1.3.2. Quick Ratio

Measures if Universe Pharmaceuticals Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Universe Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 3.09 means the company can pay off $3.09 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Universe Pharmaceuticals Inc:

  • The MRQ is 3.086. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.086. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.086TTM3.0860.000
TTM3.086YOY3.603-0.517
TTM3.0865Y3.129-0.043
5Y3.12910Y2.733+0.396

1.4. Solvency of Universe Pharmaceuticals Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Universe Pharmaceuticals Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Universe Pharmaceuticals Inc to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.26 means that Universe Pharmaceuticals Inc assets are financed with 25.8% credit (debt) and the remaining percentage (100% - 25.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Universe Pharmaceuticals Inc:

  • The MRQ is 0.258. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.258. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.258TTM0.2580.000
TTM0.258YOY0.220+0.038
TTM0.2585Y0.244+0.014
5Y0.24410Y0.313-0.068
1.4.2. Debt to Equity Ratio

Measures if Universe Pharmaceuticals Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Universe Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 34.8% means that company has $0.35 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Universe Pharmaceuticals Inc:

  • The MRQ is 0.348. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.348. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.348TTM0.3480.000
TTM0.348YOY0.282+0.066
TTM0.3485Y0.329+0.019
5Y0.32910Y0.591-0.262

2. Market Valuation of Universe Pharmaceuticals Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Universe Pharmaceuticals Inc generates.

  • Above 15 is considered overpriced but always compare Universe Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -0.56 means the investor is paying $-0.56 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Universe Pharmaceuticals Inc:

  • The EOD is -1.225. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.562. Based on the earnings, the company is expensive. -2
  • The TTM is -0.562. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.225MRQ-0.562-0.663
MRQ-0.562TTM-0.5620.000
TTM-0.562YOY-0.236-0.326
TTM-0.5625Y0.000-0.562
5Y0.00010Y0.0000.000
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Universe Pharmaceuticals Inc:

  • The EOD is 7.015. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 3.219. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 3.219. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD7.015MRQ3.219+3.795
MRQ3.219TTM3.2190.000
TTM3.219YOY-1.465+4.684
TTM3.2195Y0.235+2.984
5Y0.23510Y0.196+0.039
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Universe Pharmaceuticals Inc is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Universe Pharmaceuticals Inc:

  • The EOD is 0.191. Based on the equity, the company is cheap. +2
  • The MRQ is 0.088. Based on the equity, the company is cheap. +2
  • The TTM is 0.088. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.191MRQ0.088+0.103
MRQ0.088TTM0.0880.000
TTM0.088YOY0.044+0.043
TTM0.0885Y0.057+0.031
5Y0.05710Y0.047+0.009
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Universe Pharmaceuticals Inc.

3.1. Institutions holding Universe Pharmaceuticals Inc

Institutions are holding 0.22% of the shares of Universe Pharmaceuticals Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Acadian Asset Management LLC0.17980.0001655610.0153
2023-09-30Renaissance Technologies Corp000-4003-100
2023-09-30TWO SIGMA SECURITIES, LLC000-3080-100
2023-12-31UBS Group AG000-851-100
2023-09-30HRT FINANCIAL LLC000-2783-100
Total 0.17980.00016556-10716-163.5%

3.2. Funds holding Universe Pharmaceuticals Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Fidelity Nasdaq Composite Index0.04030146800
Total 0.04030146800.0%

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Universe Pharmaceuticals Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---1.895-1.8950%-3.426+81%2.076-191%1.807-205%
Book Value Per Share--10.84310.8430%12.738-15%9.755+11%8.206+32%
Current Ratio--2.6762.6760%3.169-16%3.100-14%2.782-4%
Debt To Asset Ratio--0.2580.2580%0.220+17%0.244+6%0.313-17%
Debt To Equity Ratio--0.3480.3480%0.282+23%0.329+6%0.591-41%
Dividend Per Share----0%-0%0.871-100%0.750-100%
Eps---1.690-1.6900%-2.396+42%0.626-370%0.582-390%
Free Cash Flow Per Share--0.2950.2950%-0.386+231%0.171+73%0.176+67%
Free Cash Flow To Equity Per Share---0.086-0.0860%0.524-116%0.889-110%0.736-112%
Gross Profit Margin--2.1012.1010%3.184-34%1.521+38%1.398+50%
Intrinsic Value_10Y_max--2.262--------
Intrinsic Value_10Y_min---27.403--------
Intrinsic Value_1Y_max--0.183--------
Intrinsic Value_1Y_min---1.799--------
Intrinsic Value_3Y_max--0.584--------
Intrinsic Value_3Y_min---6.257--------
Intrinsic Value_5Y_max--1.024--------
Intrinsic Value_5Y_min---11.616--------
Market Cap7547157.900+54%3463671.5003463671.5000%2059973.050+68%2905838.090+19%2421531.742+43%
Net Profit Margin---0.191-0.1910%-0.218+14%0.060-417%0.095-302%
Operating Margin---0.129-0.1290%-0.175+35%0.121-206%0.158-182%
Operating Ratio--1.1231.1230%1.175-4%0.875+28%0.839+34%
Pb Ratio0.191+54%0.0880.0880%0.044+98%0.057+54%0.047+85%
Pe Ratio-1.225-118%-0.562-0.5620%-0.236-58%0.000-100%0.000-100%
Price Per Share2.070+54%0.9500.9500%0.565+68%0.797+19%0.664+43%
Price To Free Cash Flow Ratio7.015+54%3.2193.2190%-1.465+146%0.235+1268%0.196+1542%
Price To Total Gains Ratio-1.092-118%-0.501-0.5010%-0.165-67%-0.144-71%-0.144-71%
Quick Ratio--3.0863.0860%3.603-14%3.129-1%2.733+13%
Return On Assets---0.116-0.1160%-0.147+27%0.117-199%0.143-181%
Return On Equity---0.156-0.1560%-0.188+21%0.164-195%0.268-158%
Total Gains Per Share---1.895-1.8950%-3.426+81%2.947-164%2.557-174%
Usd Book Value--39532701.00039532701.0000%46442323.000-15%35619268.000+11%31296318.667+26%
Usd Book Value Change Per Share---1.895-1.8950%-3.426+81%2.076-191%1.807-205%
Usd Book Value Per Share--10.84310.8430%12.738-15%9.755+11%8.206+32%
Usd Dividend Per Share----0%-0%0.871-100%0.750-100%
Usd Eps---1.690-1.6900%-2.396+42%0.626-370%0.582-390%
Usd Free Cash Flow--1075913.0001075913.0000%-1406049.000+231%652716.400+65%1262347.667-15%
Usd Free Cash Flow Per Share--0.2950.2950%-0.386+231%0.171+73%0.176+67%
Usd Free Cash Flow To Equity Per Share---0.086-0.0860%0.524-116%0.889-110%0.736-112%
Usd Market Cap7547157.900+54%3463671.5003463671.5000%2059973.050+68%2905838.090+19%2421531.742+43%
Usd Price Per Share2.070+54%0.9500.9500%0.565+68%0.797+19%0.664+43%
Usd Profit---6163061.000-6163061.0000%-8736566.000+42%2306002.400-367%3188824.167-293%
Usd Revenue--32308735.00032308735.0000%40143151.000-20%36873438.600-12%35480228.833-9%
Usd Total Gains Per Share---1.895-1.8950%-3.426+81%2.947-164%2.557-174%
 EOD+4 -4MRQTTM+0 -0YOY+19 -155Y+11 -2510Y+13 -23

4.2. Fundamental Score

Let's check the fundamental score of Universe Pharmaceuticals Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.225
Price to Book Ratio (EOD)Between0-10.191
Net Profit Margin (MRQ)Greater than0-0.191
Operating Margin (MRQ)Greater than0-0.129
Quick Ratio (MRQ)Greater than13.086
Current Ratio (MRQ)Greater than12.676
Debt to Asset Ratio (MRQ)Less than10.258
Debt to Equity Ratio (MRQ)Less than10.348
Return on Equity (MRQ)Greater than0.15-0.156
Return on Assets (MRQ)Greater than0.05-0.116
Total5/10 (50.0%)

4.3. Technical Score

Let's check the technical score of Universe Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5052.577
Ma 20Greater thanMa 502.024
Ma 50Greater thanMa 1001.827
Ma 100Greater thanMa 2001.776
OpenGreater thanClose2.170
Total5/5 (100.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-09-302020-09-302021-09-302022-09-302023-09-30
Net Debt  -656-6,757-7,4123,669-3,7441,968-1,7751,972197



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets53,287
Total Liabilities13,754
Total Stockholder Equity39,533
 As reported
Total Liabilities 13,754
Total Stockholder Equity+ 39,533
Total Assets = 53,287

Assets

Total Assets53,287
Total Current Assets36,810
Long-term Assets16,477
Total Current Assets
Cash And Cash Equivalents 5,285
Short-term Investments 13,219
Net Receivables 10,729
Inventory 3,343
Other Current Assets 626
Total Current Assets  (as reported)36,810
Total Current Assets  (calculated)33,203
+/- 3,607
Long-term Assets
Property Plant Equipment 14,986
Long Term Investments 685
Intangible Assets 149
Long-term Assets  (as reported)16,477
Long-term Assets  (calculated)15,820
+/- 657

Liabilities & Shareholders' Equity

Total Current Liabilities13,754
Long-term Liabilities0
Total Stockholder Equity39,533
Total Current Liabilities
Short-term Debt 5,482
Short Long Term Debt 5,482
Accounts payable 4,585
Other Current Liabilities 3,687
Total Current Liabilities  (as reported)13,754
Total Current Liabilities  (calculated)19,237
+/- 5,482
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock68
Retained Earnings 10,159
Accumulated Other Comprehensive Income 26
Other Stockholders Equity 29,279
Total Stockholder Equity (as reported)39,533
Total Stockholder Equity (calculated)39,533
+/-0
Other
Capital Stock68
Cash and Short Term Investments 18,504
Common Stock Shares Outstanding 3,625
Liabilities and Stockholders Equity 53,287
Net Debt 197
Net Invested Capital 45,015
Net Working Capital 23,056
Property Plant and Equipment Gross 21,036
Short Long Term Debt Total 5,482



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-09-302022-09-302021-09-302020-09-302019-09-302018-09-30
> Total Assets 
28,079
17,837
28,804
70,145
59,540
53,287
53,28759,54070,14528,80417,83728,079
   > Total Current Assets 
21,956
12,230
23,280
50,481
41,506
36,810
36,81041,50650,48123,28012,23021,956
       Cash And Cash Equivalents 
6,190
3,177
10,058
8,078
5,711
5,285
5,2855,7118,07810,0583,1776,190
       Short-term Investments 
0
0
0
13,725
13,149
13,219
13,21913,14913,725000
       Net Receivables 
7,637
6,421
10,872
15,811
15,184
10,729
10,72915,18415,81110,8726,4217,637
       Inventory 
8,120
2,615
1,906
2,463
2,206
3,343
3,3432,2062,4631,9062,6158,120
       Other Current Assets 
8
16
444
10,405
1,724
626
6261,72410,405444168
   > Long-term Assets 
6,122
5,607
5,524
19,664
18,034
16,477
16,47718,03419,6645,5245,6076,122
       Property Plant Equipment 
5,076
4,567
4,428
15,394
13,577
14,986
14,98613,57715,3944,4284,5675,076
       Long Term Investments 
728
701
735
745
703
685
685703745735701728
       Intangible Assets 
184
172
175
178
157
149
149157178175172184
       Other Assets 
135
168
187
14,059
12,923
0
012,92314,059187168135
> Total Liabilities 
18,397
5,453
8,001
11,210
13,098
13,754
13,75413,09811,2108,0015,45318,397
   > Total Current Liabilities 
18,397
5,453
8,001
11,210
13,098
13,754
13,75413,09811,2108,0015,45318,397
       Short-term Debt 
2,621
2,522
2,646
4,334
3,936
5,482
5,4823,9364,3342,6462,5222,621
       Short Long Term Debt 
2,621
2,522
2,646
4,334
3,936
5,482
5,4823,9364,3342,6462,5222,621
       Accounts payable 
2,938
1,937
2,691
5,311
3,075
4,585
4,5853,0755,3112,6911,9372,938
       Other Current Liabilities 
11,944
994
2,664
1,566
6,086
3,687
3,6876,0861,5662,66499411,944
   > Long-term Liabilities 
0
4,459
5,337
9,645
7,012
0
07,0129,6455,3374,4590
> Total Stockholder Equity
9,682
12,384
20,803
58,934
46,442
39,533
39,53346,44258,93420,80312,3849,682
   Common Stock
50
50
50
68
68
68
686868505050
   Retained Earnings 
2,832
6,181
13,739
25,059
16,322
10,159
10,15916,32225,05913,7396,1812,832
   Accumulated Other Comprehensive Income 
3,120
2,474
3,335
4,528
773
26
267734,5283,3352,4743,120
   Capital Surplus 000000
   Treasury Stock000000
   Other Stockholders Equity 
3,679
3,679
3,679
29,279
29,279
29,279
29,27929,27929,2793,6793,6793,679



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-09-30)

Gross Profit (+$)
totalRevenue32,309
Cost of Revenue-21,994
Gross Profit10,31510,315
 
Operating Income (+$)
Gross Profit10,315
Operating Expense-14,281
Operating Income-3,527-3,966
 
Operating Expense (+$)
Research Development4,859
Selling General Administrative2,217
Selling And Marketing Expenses6,784
Operating Expense14,28113,859
 
Net Interest Income (+$)
Interest Income0
Interest Expense-157
Other Finance Cost-0
Net Interest Income-157
 
Pretax Income (+$)
Operating Income-3,527
Net Interest Income-157
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-3,850-3,800
EBIT - interestExpense = -4,327
-3,850
-6,006
Interest Expense157
Earnings Before Interest and Taxes (EBIT)-4,171-3,693
Earnings Before Interest and Taxes (EBITDA)-3,662
 
After tax Income (+$)
Income Before Tax-3,850
Tax Provision-2,313
Net Income From Continuing Ops-6,163-6,163
Net Income-6,163
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses36,275
Total Other Income/Expenses Net273157
 

Technical Analysis of Universe Pharmaceuticals Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Universe Pharmaceuticals Inc. The general trend of Universe Pharmaceuticals Inc is BULLISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Universe Pharmaceuticals Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (71.4%) Bearish trend (-71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Universe Pharmaceuticals Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 2.85 < 2.88 < 2.88.

The bearish price targets are: 1.5656 > 1.37 > 1.1373.

Tweet this
Universe Pharmaceuticals Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Universe Pharmaceuticals Inc. The current mas is .

The long score for the Moving Averages is 12/14.
The longshort score for the Moving Averages is 10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Universe Pharmaceuticals Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Universe Pharmaceuticals Inc. The current macd is 0.04127271.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Universe Pharmaceuticals Inc price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Universe Pharmaceuticals Inc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Universe Pharmaceuticals Inc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Universe Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) ChartUniverse Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Universe Pharmaceuticals Inc. The current adx is 22.25.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Universe Pharmaceuticals Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Universe Pharmaceuticals Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Universe Pharmaceuticals Inc. The current sar is 2.53184212.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Universe Pharmaceuticals Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Universe Pharmaceuticals Inc. The current rsi is 52.58. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
Universe Pharmaceuticals Inc Daily Relative Strength Index (RSI) ChartUniverse Pharmaceuticals Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Universe Pharmaceuticals Inc. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Universe Pharmaceuticals Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Universe Pharmaceuticals Inc Daily Stochastic Oscillator ChartUniverse Pharmaceuticals Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Universe Pharmaceuticals Inc. The current cci is 11.39.

Universe Pharmaceuticals Inc Daily Commodity Channel Index (CCI) ChartUniverse Pharmaceuticals Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Universe Pharmaceuticals Inc. The current cmo is 6.12152553.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Universe Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) ChartUniverse Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Universe Pharmaceuticals Inc. The current willr is -60.72874494.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Universe Pharmaceuticals Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Universe Pharmaceuticals Inc Daily Williams %R ChartUniverse Pharmaceuticals Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Universe Pharmaceuticals Inc.

Universe Pharmaceuticals Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Universe Pharmaceuticals Inc. The current atr is 0.32438952.

Universe Pharmaceuticals Inc Daily Average True Range (ATR) ChartUniverse Pharmaceuticals Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Universe Pharmaceuticals Inc. The current obv is 3,261,100.

Universe Pharmaceuticals Inc Daily On-Balance Volume (OBV) ChartUniverse Pharmaceuticals Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Universe Pharmaceuticals Inc. The current mfi is 59.07.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Universe Pharmaceuticals Inc Daily Money Flow Index (MFI) ChartUniverse Pharmaceuticals Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Universe Pharmaceuticals Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-27BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-03ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-12RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-23CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-24SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-31CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-01CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-14WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-19CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-21CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-28CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-02ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-15CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Universe Pharmaceuticals Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Universe Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5052.577
Ma 20Greater thanMa 502.024
Ma 50Greater thanMa 1001.827
Ma 100Greater thanMa 2001.776
OpenGreater thanClose2.170
Total5/5 (100.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Universe Pharmaceuticals Inc with someone you think should read this too:
  • Are you bullish or bearish on Universe Pharmaceuticals Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Universe Pharmaceuticals Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Universe Pharmaceuticals Inc

I send you an email if I find something interesting about Universe Pharmaceuticals Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Universe Pharmaceuticals Inc.

Receive notifications about Universe Pharmaceuticals Inc in your mailbox!